Moore, G.; Lightner, C.; Elbai, S.; Brady, L.; Nicholson, S.; Ryan, R.; O’Sullivan, K.E.; O’Byrne, K.J.; Blanco-Aparicio, C.; Cuffe, S.;
et al. Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC. Cancers 2021, 13, 2139.
https://doi.org/10.3390/cancers13092139
AMA Style
Moore G, Lightner C, Elbai S, Brady L, Nicholson S, Ryan R, O’Sullivan KE, O’Byrne KJ, Blanco-Aparicio C, Cuffe S,
et al. Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC. Cancers. 2021; 13(9):2139.
https://doi.org/10.3390/cancers13092139
Chicago/Turabian Style
Moore, Gillian, Clara Lightner, Samira Elbai, Lauren Brady, Siobhan Nicholson, Ronan Ryan, Katie E. O’Sullivan, Kenneth J. O’Byrne, Carmen Blanco-Aparicio, Sinead Cuffe,
and et al. 2021. "Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC" Cancers 13, no. 9: 2139.
https://doi.org/10.3390/cancers13092139
APA Style
Moore, G., Lightner, C., Elbai, S., Brady, L., Nicholson, S., Ryan, R., O’Sullivan, K. E., O’Byrne, K. J., Blanco-Aparicio, C., Cuffe, S., O’Neill, M., Heavey, S., Finn, S. P., & Gately, K.
(2021). Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC. Cancers, 13(9), 2139.
https://doi.org/10.3390/cancers13092139